These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30183599)

  • 1. From VEDOSS to established systemic sclerosis diagnosis according to ACR/EULAR 2013 classification criteria: a French-Italian capillaroscopic survey.
    Vasile M; Avouac J; Sciarra I; Stefanantoni K; Iannace N; Cravotto E; Valesini G; Allanore Y; Riccieri V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):82-87. PubMed ID: 30183599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nailfold Capillaroscopy - Its Role in Diagnosis and Differential Diagnosis of Microvascular Damage in Systemic Sclerosis.
    Lambova S; Hermann W; Muller-Ladner U
    Curr Rheumatol Rev; 2013; 9(4):254-60. PubMed ID: 26932290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
    Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M;
    Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated structure and flow measurement - a promising tool in nailfold capillaroscopy.
    Berks M; Dinsdale G; Murray A; Moore T; Manning J; Taylor C; Herrick AL
    Microvasc Res; 2018 Jul; 118():173-177. PubMed ID: 29605552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis?
    Riccieri V; Germano V; Alessandri C; Vasile M; Ceccarelli F; Sciarra I; Di Franco M; Spadaro A; Valesini G
    Clin Exp Rheumatol; 2008; 26(6):992-7. PubMed ID: 19210861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review.
    Paxton D; Pauling JD
    Semin Arthritis Rheum; 2018 Dec; 48(3):482-494. PubMed ID: 29602558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillaroscopy changes are associated with disease progression in patients with early systemic sclerosis: A prospective study.
    Zumstein Camargo C; Kayser C
    Int J Rheum Dis; 2019 Jul; 22(7):1319-1326. PubMed ID: 31050209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice.
    Jordan S; Maurer B; Toniolo M; Michel B; Distler O
    Rheumatology (Oxford); 2015 Aug; 54(8):1454-8. PubMed ID: 25762528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern.
    Yalçınkaya Y; Adın-Çınar S; Artim-Esen B; Kamalı S; Pehlivan Ö; Öcal L; Deniz G; Inanç M
    Microvasc Res; 2016 Nov; 108():17-21. PubMed ID: 27392528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
    Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
    Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis.
    Pizzorni C; Giampetruzzi AR; Mondino C; Facchiano A; Abeni D; Paolino S; Ruaro B; Smith V; Sulli A; Cutolo M
    Microvasc Res; 2017 May; 111():20-24. PubMed ID: 27989404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities.
    Riccieri V; Rinaldi T; Spadaro A; Scrivo R; Ceccarelli F; Franco MD; Taccari E; Valesini G
    Clin Rheumatol; 2003 May; 22(2):102-6. PubMed ID: 12740673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging application of semi-quantitative and quantitative capillaroscopy in systemic sclerosis.
    Mihai C; Smith V; Dobrota R; Gheorghiu AM; Cutolo M; Distler O
    Microvasc Res; 2018 Jul; 118():113-120. PubMed ID: 29544760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-occlusive reactive hyperaemia (POHR) in systemic sclerosis: very early disease (VEDOSS) represents a separate entity compared to established disease.
    Della Rossa A; D'Ascanio A; Barsotti S; Stagnaro C; Mosca M
    Scand J Rheumatol; 2016 Oct; 45(5):408-11. PubMed ID: 26948487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.
    Smith V; Riccieri V; Pizzorni C; Decuman S; Deschepper E; Bonroy C; Sulli A; Piette Y; De Keyser F; Cutolo M
    J Rheumatol; 2013 Dec; 40(12):2023-8. PubMed ID: 24128778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon.
    Bissell LA; Abignano G; Emery P; Del Galdo F; Buch MH
    BMC Musculoskelet Disord; 2016 Aug; 17(1):342. PubMed ID: 27526772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques.
    Ruaro B; Sulli A; Smith V; Pizzorni C; Paolino S; Alessandri E; Cutolo M
    Reumatismo; 2017 Dec; 69(4):147-155. PubMed ID: 29320840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?
    Cutolo M; Smith V
    Rheumatology (Oxford); 2013 Nov; 52(11):1933-40. PubMed ID: 23620555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.